Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$3.24 USD
-0.07 (-2.11%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $3.23 -0.01 (-0.31%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.04 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 75.00% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.10 |
Next Year | 0.01 |
EPS (TTM) | -0.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 35.35M | 36.13M | 146.07M | 176.27M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 36.30M | 37.00M | 151.40M | 177.60M |
Low Estimate | 34.75M | 35.70M | 142.82M | 175.00M |
Year ago Sales | 31.76M | 31.43M | 127.04M | 146.07M |
Year over Year Growth Est. | 11.30% | 14.96% | 14.98% | 20.67% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.04 | -0.03 | -0.10 | 0.01 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.02 | -0.01 | -0.03 | 0.06 |
Low Estimate | -0.05 | -0.05 | -0.17 | -0.05 |
Year ago EPS | -0.35 | -0.17 | -0.80 | -0.10 |
Year over Year Growth Est. | 88.57% | 82.35% | 87.50% | 110.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.04 | -0.03 | -0.10 | 0.01 |
7 Days Ago | -0.04 | -0.03 | -0.10 | 0.01 |
30 Days Ago | -0.04 | -0.03 | -0.10 | 0.01 |
60 Days Ago | -0.04 | -0.03 | -0.14 | -0.02 |
90 Days Ago | -0.06 | -0.06 | -0.22 | -0.09 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.04 | -0.03 | -0.10 | 0.01 |
Zacks Consensus Estimate | -0.04 | -0.03 | -0.10 | 0.01 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | -0.07 | -0.17 | -0.35 | NA |
Estimate | -0.08 | -0.15 | -0.31 | -0.23 | NA |
Difference | 0.06 | 0.08 | 0.14 | -0.12 | 0.04 |
Surprise | 75.00% | 53.33% | 45.16% | -52.17% | 30.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more